Product Information
TROKENDI XR 200 MG CAPSULE is a brand product labeled by Supernus Pharmaceuticals Inc., priced at $43.6510 per EA under NDC 17772010430. Its NADAC has been published 451 times since Nov 8, 2017.
Strength
200 mg/1
Manufacturer
Supernus Pharmaceuticals Inc.NDC
17772010430
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TOPIRAMATEApproval Type
New Drug (NDA)
FDA Application
NDA201635On Market Since
8/16/2013
Pharmacological Classes
Price Statistics
The NADAC for TROKENDI XR 200 MG CAPSULE has been published 451 times since Nov 8, 2017, and over the history we have for it it has risen 57.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $43.6510 per EA |
|---|---|
| All-time high | $43.8836 (Feb 11, 2026) |
| All-time low | $27.6977 (Nov 22, 2017) |
| 52-week high | $43.8836 |
| 52-week low | $41.3997 |
| Median price | $39.2215 |
| Average price | $37.4854 |
| Largest weekly change | +8.0% (Jan 10, 2018) |
| Weeks tracked | 451 |
| Tracking since | Nov 8, 2017 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TROKENDI XR 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TROKENDI XR 200 MG CAPSULE, manufactured by Supernus Pharmaceuticals Inc., is $43.6510 per EA (NDC 17772010430), effective Jun 24, 2026.
How has the price of TROKENDI XR 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TROKENDI XR 200 MG CAPSULE has risen 57.1%. It has been tracked across 451 weekly CMS publications since Nov 8, 2017.
What are the highest and lowest recorded NADAC prices for TROKENDI XR 200 MG CAPSULE?
Since Nov 8, 2017, the NADAC for TROKENDI XR 200 MG CAPSULE has ranged from a low of $27.6977 (Nov 22, 2017) to a high of $43.8836 (Feb 11, 2026), with a median of $39.2215 per EA.
Are there cheaper alternatives to TROKENDI XR 200 MG CAPSULE?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TOPIRAMATE 200 MG TABLET, is $0.1069 per EA — about 100% below TROKENDI XR 200 MG CAPSULE.
Who manufactures TROKENDI XR 200 MG CAPSULE?
TROKENDI XR 200 MG CAPSULE (NDC 17772010430) is labeled by Supernus Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification